Physician profile
Mohammed Qureshi
NPI 1578057642
$1,989.90
in general payments reported to CMS, 2019-2025
17 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $272 · 2021: $1,254 · 2022: $94.94 · 2023: $34.23 · 2024: $73.04 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,210.44 | 2021 | |
| Cardiovascular Systems INC. | $123.21 | 2020 | |
| Zimmer Biomet Holdings, INC. | $117.59 | 2020 | |
| Kci USA, INC. | $117.28 | 2019 | |
| Amgen INC. | $71.71 | 2024-2025 | Krystexxa |
| Inari Medical, INC. | $43.76 | 2021 | |
| Smith+Nephew, INC. | $43.08 | 2024-2025 | Q-Fix, Stravix |
| Depuy Synthes Sales INC. | $39.95 | 2022 | |
| Melinta Therapeutics, LLC | $36.81 | 2022 | |
| Abbvie INC. | $34.23 | 2023 | |
| Paragon 28, INC. | $28.50 | 2019-2020 | |
| Ermi LLC | $24.62 | 2025 | |
| Biopro, INC. | $21.91 | 2019 | |
| Osteomed LLC | $21.06 | 2020 | |
| Integra Lifesciences Corporation | $20.23 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $18.18 | 2022 | |
| Djo, LLC | $17.34 | 2025 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.